Come up with a name for your new list and we'll add to it:
Molecular Insight Pharmaceuticals raised a round of funding on July 02, 2009. Investors include
National Cancer Institute.
Molecular Insight is a clinical-stage biopharmaceutical company focused on the critical unmet diagnostic and therapeutic needs of the prostate cancer patient. The Company is targeting the development …